The Genetic Testing market forecast report identifies growth opportunities in the market and how companies are reacting to the current market conditions. Genetic Testing Companies are focusing on improving efficiency and containing costs in current economically challenging conditions. Genetic Testing market forecast and Genetic Testing market growth is outlook through 2030.
The report reflects on predictions with 2022 as the base year and 2023-2030 as the forecast period. The research was based on the findings of expert team of analysts analyzing the Genetic Testing market opportunities, underlying market factors, demographic and economic factors, market developments and others.
Genetic Testing industry size is estimated to register strong growth over the forecast period driven by ongoing investments in product diversification and expansion strategies in developing countries in Asia Pacific and South and Central America while opting for strengthening Genetic Testing market share in developed countries.
Scope of the research
Global Genetic Testing Market is analyzed and forecast over the outlook period from 2023 to 2030 By type including
- Predictive and Presymptomatic Testing
- Carrier Testing
- Prenatal and Newborn Testing
- Diagnostic Testing
- Pharmacogenomic Testing
- Others
Global Genetic Testing Market is analyzed and forecast over the outlook period from 2023 to 2030 By technology including
- Cytogenetic Testing
- Biochemical Testing
- Molecular Testing
- Others
Global Genetic Testing Market is analyzed and forecast over the outlook period from 2023 to 2030 By Disease
- Alzheimer
- Oncology
- Cystic Fibrosis
- Sickle Cell Anemia
- Duchenne Muscular
- Thalasemia
- Huntingtons Disease
- Rare Disease
- Others
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- 23 and Me
- Abbott Laboratories
- Bio-Rad Laboratories
- Danaher Corporation
- Eurofins Scientific
- GEnesis Healthcare
- Illumina
- Luminex Corporation
- Myriad GEnetics
- Precipio

